NP / PA
Kozlosky, Kimberly
Kozlosky, Kimberly was paid $96K by Medicaid between Jan 2022 and Aug 2024, across 16 billing codes. Its largest line is 87591, Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe — 19% of everything it billed.
33Billing provider infoKOZLOSKY, KIMBERLY
BRONX, NY 10461
BRONX, NY 10461
33aNPI1437776978assigned 07/01/2020
33bProvider typeWomen's Health Nurse Practitioner
28Total paid$96K
24GClaims2,498
24DCodes billed16
24AFirst – last monthJan 2022 – Aug 2024
Compared with peers
Next to other Women's Health Nurse Practitioner providers in New York
Rank by total paid#4 of 43
Median peer was paid$1K
This provider vs. median73×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 958 | $18K | |
| 2023 | 1,142 | $52K | |
| 2024incomplete | 398 | $27K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 19% | 201 | 185 | $18K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 18% | 198 | 184 | $18K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 277 | 268 | $13K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 10% | 134 | 116 | $10K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 9.9% | 183 | 164 | $10K |
| 99442 | 7.0% | 152 | 141 | $7K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 5.4% | 329 | 328 | $5K |
| 99441 | 5.1% | 174 | 152 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.6% | 74 | 70 | $3K |
| 86780 | 2.1% | 76 | 71 | $2K | |
| 87522 | Neg quan hep c or qual rna | 1.9% | 17 | 17 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.6% | 27 | 27 | $2K |
4 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.